Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Zomedica Corp. Common Shares (NY:ZOM)

0.0973 UNCHANGED
Last Price Updated: 8:00 PM EST, Mar 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zomedica Corp. Common Shares

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
News headline image
Zomedica to Present at the Sidoti Small Cap Conference March 14, 2024
Via ACCESSWIRE
News headline image
3 High-Reward Penny Stocks to Uncover Big Gains ↗
Dive into the realm of high-reward penny stocks. The article gives the insights you need to spot quality plays and make informed decisions. 
Via InvestorPlace
News headline image
Zomedica Announces Sponsorship of Educational Presentations at Major Veterinary Health Conferences
Via ACCESSWIRE
News headline image
7 Penny Stocks to Buy on the Dip: February 2024 ↗
With the markets turning lower, these penny stocks to buy stand out as attractive options. Consider these seven stocks. 
Via InvestorPlace
News headline image
Leading Independent Proxy Advisory Firm Glass Lewis Recommends Zomedica Shareholders Vote for the Share Consolidation (Reverse Stock Split)
Via ACCESSWIRE
News headline image
Zomedica to Host Virtual Investor Day February 13 at 3:00 p.m. ET
Via ACCESSWIRE
News headline image
3 Hidden-Gem Penny Stocks That Could Yield Life-Changing Wealth ↗
Unlock the secret to wealth with insights on ZOM, SNDL, and BLDE. Discover how these penny stocks could redefine your future. 
Via InvestorPlace
News headline image
Open Letter to Zomedica Shareholders from your Chief Executive Officer
Via ACCESSWIRE
News headline image
Zomedica to Participate in the Lytham Partners 2024 Investor Select Conference
Via ACCESSWIRE
News headline image
Leading Proxy Advisory Firm ISS Recommends Zomedica Shareholders Vote "FOR" Proposed Reverse Stock Split
Via ACCESSWIRE
News headline image
Zomedica Announces Preliminary 2023 Revenue; Provides Revenue Guidance for 2024, and Rationale for Share Consolidation ("Reverse Stock Split")
Via ACCESSWIRE
News headline image
3 Breakout Penny Stocks Primed for Massive Gains ↗
Discover three penny stocks poised for breakout success in veterinary, liquor retail, and insurance sectors. 
Via InvestorPlace
News headline image
Zomedica Corp. to Host Conference Call on January 17, 2024, at 4:30 p.m. ET to Provide a Business Update, Preliminary 2023 Revenue and Cash Position, and Discuss the Proposed Reverse Stock Split; Provides Notice of Special Virtual-Only Meeting of
Via ACCESSWIRE
News headline image
Budget Bets: Top 3 Penny Stocks with Potential for Explosive Growth ↗
These cheap stocks offer investors an extreme risk to reward tradeoff, which might be worth considering for lucrative payoffs. 
Via InvestorPlace
News headline image
Zomedica Announces Publication of Research Validating Better Patient Acceptance of PulseVet(R) Electro-hydraulic Shock Wave Therapy without Sedation Utilizing Novel “X-Trode” Handpiece
Via ACCESSWIRE
News headline image
Zomedica Announces Expansion of Market Opportunity for TRUFORMA(R) Diagnostic Platform with Launch of Three New Assays for Commonly Performed Diagnostic Tests for Canine Gastrointestinal Disease
Via ACCESSWIRE
News headline image
Zomedica Announces Presentation of Clinical Data in Support of New Indications for PulseVet Shock Wave Therapy at Annual Meeting of American Association of Equine Practitioners
Via ACCESSWIRE
News headline image
Zomedica to Present at Noble Capital Markets' 19th Annual Emerging Growth Equity Conference
Via ACCESSWIRE
News headline image
Zomedica to Present at the 35th Annual Piper Sandler Healthcare Conference
Via ACCESSWIRE
News headline image
Zomedica Announces Record Third Quarter 2023 Financial Results: Revenue up 31% to $6.3 Million; 69% Gross Margin, and $118 Million in Liquidity, while Making Strategic Acquisitions of Structured Monitoring Products and Qorvo Biotechnologies
Via ACCESSWIRE
News headline image
Earnings Scheduled For November 13, 2023 ↗
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter. 
Via Benzinga
News headline image
Zomedica to Report Third Quarter 2023 Financial Results and Provide Business Update on November 13 at 4:30 p.m. ET
Via ACCESSWIRE
News headline image
Zomedica to Participate in the Lytham Partners Fall 2023 Investor Conference
Via ACCESSWIRE
News headline image
Zomedica Announces Acquisition of TRUFORMA Platform Developer Qorvo Biotech LLC, Accelerating Timeline to Gain Control of Manufacturing and Research & Development
Via ACCESSWIRE
News headline image
Zomedica Announces Expansion of Market Opportunity for TRUFORMA(R) Diagnostic Platform with Launch of First-and-only Point of Care eACTH Assay for Diagnosis and Management of Cushing’s Disease in Horses
Via ACCESSWIRE
News headline image
Zomedica Provides Corporate Update
Via ACCESSWIRE
News headline image
7 Biotech Stocks to Sell in September Before They Crash & Burn ↗
These are just a few of the top biotech stocks to sell today - especially with each of the firms dealing with legitimate issues. 
Via InvestorPlace
News headline image
Zomedica Closes Acquisition of Structured Monitoring Products Adding Revolutionary VetGuardian Touchless Vital Signs Monitor to Product Portfolio
Via ACCESSWIRE
News headline image
Zomedica to Present at H.C. Wainwright 24th Annual Global Investment Conference
Via ACCESSWIRE
News headline image
Zomedica Announces Record Second Quarter 2023 Financial Results: Revenue up 43% to $6.0 Million; Strong 67% Gross Margin & $142.4 Million in Liquidity
Via ACCESSWIRE
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.